Table 1.
Distribution of WHO scores according to the demographic and clinical characteristics of the 56 subjects
| WHO score ≥ 5 (N = 27) |
WHO score < 5 (N = 29) |
p value | |
|---|---|---|---|
| Sex | |||
| Female, N (%) | 9 (33) | 17 (59) | 0.104 |
| Male, N (%) | 18 (67) | 12 (41) | |
| Age, years | |||
| Mean ± SD | 66 (12) | 65 (19) | 0.856 |
| < 65, N (%) | 13 (48) | 15 (52) | 0.074 |
| 65–75, N (%) | 10 (37) | 4 (14% | |
| > 75, N (%) | 4 (15) | 10 (34) | |
| Cardiovascular comorbidities | |||
| No, N (%) | 22 (85) | 18 (72) | 0.451 |
| Yes, N (%) | 4 (15) | 7 (28) | |
| Opportunistic Infections | |||
| No, N (%) | 7 (26) | 23 (79) | 0.000 |
| Yes, N (%) | 20 (74) | 6 (21) | |
| Death | |||
| No, N (%) | 18 (67) | 28 (97) | 0.010 |
| Yes, N (%) | 9 (33) | 1 (3) | |
| D-dimero, median (IQR) | 2734 (733–8647) | 473 (205–2479) | 0.275 |
| PCR, median (IQR) | 106 (27–209) | 9 (4–68) | 0.370 |
| First COVID-19 test, median (IQR) | 24.5 (18–27) | 21.5 (15–30.5) | 0.257 |